Nutex Health, Inc.

NASDAQ:NUTX

122.02 (USD) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22011 Q42011 Q32011 Q22011 Q12010 Q42010 Q32010 Q22010 Q1
Revenue 211.789257.61878.79576.08267.45469.66962.72358.92456.32953.72428.39558.0486.20965.026117.97262.8152.014106.1330.5610.6430.6652.1510.0180.0140.0140.0370.030.0120.012-0.5940.0270.0190.7060.6010.6990.5420.4930.2150.3430.215
Cost of Revenue 93.451115.99256.87853.52157.29756.45655.65749.27851.48253.19454.86453.0554.49364.75441.96333.6771.5870.470.4220.530.3981.6610000.0470.016000.3980.01600.4440.3820.4430.260.3990.0960.1930.096
Gross Profit 118.338141.62621.91722.56110.15713.2137.0669.6474.8480.53-26.4684.9931.7160.27276.00829.1370.427105.6640.1390.1140.2670.490.0180.0140.014-0.0090.0150.0120.012-0.9920.0110.0190.2620.2190.2560.2820.0940.1190.150.119
Gross Profit Ratio 0.5590.550.2780.2970.1510.190.1130.1640.0860.01-0.9320.0860.2760.0040.6440.4640.2120.9960.2480.1770.4010.228111-0.2530.485111.670.4110.3720.3650.3660.520.1910.5550.4370.555
Reseach & Development Expenses 000000000-0.074000.0740.2090.0720.060.0770.0540.0740.3140.1150.768000000000000000000
General & Administrative Expenses 10.03527.42811.82910.5918.7089.1377.84410.0099.0766.3094.0772.48517.783-103.3341.5461.5334.42641.0890.6991.3420.8363.0910.1870.1990.190.4110.2080.3110.2340.6070.7231.2390.5020.4590.4510.4520.5410.430.4290.43
Selling & Marketing Expenses 000000.637000-0.011000.0110.0150.0050.0070.01-0.002-0.0050.0530.1210.578000000000000000000
SG&A 10.03527.42811.82910.5918.7089.1377.84410.0099.0766.3094.0772.48517.794-103.3341.5461.5334.43641.0890.6931.3940.9573.6680.1870.1990.190.4110.2080.3110.2340.6070.7231.2390.5020.4590.4510.4520.5410.430.4290.43
Other Expenses 0-0.0120.4256.6710-0.3280.0530.1240.2170.0740.631.4030.216-1.8691.7454.060.064-1.0130000.2380.1740.1740.1740.1270.1580.1740.1743.8720000000000
Operating Expenses 10.03527.41712.25417.2628.7089.1377.84410.0099.2936.3094.0772.48518.084-109.2071.5461.5334.57742.8020.7671.7091.0724.6750.3610.3730.3640.5380.3660.4850.4080.6070.7231.2390.5020.4590.4510.4520.5410.430.4290.43
Operating Income 72.209114.2099.6635.2991.454.077-0.778-0.363-4.445-5.779-439.0123.91-16.36818.42974.46327.604-4.1563.332-0.628-1.683-0.94-5.792-0.364-0.375-0.367-0.563-0.367-0.489-0.412-3.493-0.712-1.249-0.24-0.239-0.195-0.171-0.447-0.31-0.279-0.31
Operating Income Ratio 0.3410.4430.1230.070.0210.059-0.012-0.006-0.079-0.108-15.4610.067-2.6360.2830.6310.439-2.060.597-1.12-2.615-1.414-2.692-20.677-26.045-27.129-15.117-12.066-42.083-33.9855.884-26.403-65.619-0.339-0.398-0.279-0.315-0.906-1.441-0.815-1.441
Total Other Income Expenses Net -9.445-5.631-12.243-1.395-1.602-4.565-4.045-4.72-3.388-3.074-2.772-2.446-4.237-21.1160.4852.555-0.334-2.7552.3841.91-0.1830.179-0.01-0.196-0.192-0.307-0.242-0.237-0.198-0.3717.037-0.3990.0070.0080.0070.0070.007000
Income Before Tax 62.764108.578-2.583.904-0.153-30.71-4.866-5.082-7.833-8.853-441.784-3.825-16.57814.61674.94830.16-4.48460.5761.7560.227-1.123-5.613-0.374-0.57-0.559-0.869-0.609-0.726-0.61-3.8646.325-1.647-0.233-0.231-0.188-0.163-0.44-0.31-0.279-0.31
Income Before Tax Ratio 0.2960.421-0.0330.051-0.002-0.441-0.078-0.086-0.139-0.165-15.558-0.066-2.670.2250.6350.48-2.2260.5713.1310.353-1.689-2.609-21.245-39.644-41.337-23.363-20.007-62.5-50.3246.51234.573-86.574-0.33-0.385-0.269-0.302-0.892-1.439-0.814-1.439
Income Tax Expense 18.5418.6094.5850.8940.39-2.999-0.342-0.816-0.9111.805-8.54419.653-0.009-0.440.4540.482-0.0420.323-0.053-0.051-0.047-0.046-0.045-0.041-0.0400000.07800-0.08-0.078-0.066-0.209-1.146-0.121-0.108-0.121
Net Income 44.22361.696-8.788-0.364-0.364-31.618-5.542-3.479-5.147-10.659-433.241-23.478-16.56915.05653.79327.059-4.44540.2541.7560.227-1.123-5.613-0.374-0.57-0.559-0.869-0.609-0.726-0.61-3.9426.325-1.647-0.153-0.153-0.1220.046-0.3590.1560.2050.156
Net Income Ratio 0.2090.239-0.112-0.005-0.005-0.454-0.088-0.059-0.091-0.198-15.258-0.404-2.6690.2320.4560.431-2.2060.3793.1310.353-1.689-2.609-21.245-39.644-41.337-23.363-20.007-62.5-50.3246.641234.573-86.574-0.217-0.255-0.1750.084-0.7280.7260.5980.726
EPS 8.67111,954.48-1,723.19-0.073-0.075-7.86-1.5-0.98-1.27-2.35-100.04-5.48-4.193.2313.56.85-1.128.50.340.049-0.24-1.55-0.083-0.1-0.1-0.12-0.084-0.11-0.1-0.941.78-0.56-0.13-0.13-0.10.038-0.30.130.170.13
EPS Diluted 8.67111,954.48-1,723.19-0.073-0.075-7.5-1.25-0.79-1.11-2.17-100.04-5.45-4.193.8113.616.85-1.128.50.340.049-0.24-1.55-0.083-0.1-0.1-0.12-0.084-0.11-0.1-0.941.78-0.56-0.13-0.13-0.10.038-0.30.130.170.13
EBITDA 73.976118.9117.77313.4918.478-21.7913.9783.814-0.699-2.674-423.3293.265-15.673-2.032-0.047-0.558-4.08564.0441.7790.568-0.94-5.792-0.364-0.375-0.367-0.563-0.367-0.489-0.412-3.493-0.712-1.249-0.24-0.239-0.195-0.171-0.447-0.31-0.279-0.31
EBITDA Ratio 0.3490.4620.0990.1770.126-0.3130.0630.065-0.012-0.05-14.9090.056-2.524-0.031-0-0.009-2.0280.6033.1710.883-1.414-2.692-20.677-26.045-27.129-15.117-12.066-42.083-33.9855.884-26.403-65.619-0.339-0.398-0.279-0.315-0.906-1.441-0.815-1.441